← Eichor
Condition: Xlp Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Xlp

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001350Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency
Phase 1 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07433621Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Longitudinal Study of the Porphyrias
Phase N/A · 16 location(s) · The American Porphyrias Expert Collaborative · NCT01561157Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
Phase N/A · 19 location(s) · Portal Therapeutics, Inc. · NCT07567131Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06781437Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Proto
Phase 3 · 51 location(s) · Tanabe Pharma America, Inc. · NCT05005975Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoprolife
Phase 2 · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06730126
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.